Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pCMV-SHP2 CS Citations (6)

Originally described in: SHP2 plasmids

Articles Citing pCMV-SHP2 CS

Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium. Grinnell KL, Casserly B, Harrington EO. Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L361-70. doi: 10.1152/ajplung.00374.2009. Epub 2009 Dec 18. PubMed
The p75 receptor mediates axon growth inhibition through an association with PIR-B. Fujita Y, Takashima R, Endo S, Takai T, Yamashita T. Cell Death Dis. 2011 Sep 1;2:e198. doi: 10.1038/cddis.2011.85. PubMed
Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4. Cooke M, Orlando U, Maloberti P, Podesta EJ, Cornejo Maciel F. J Lipid Res. 2011 Nov;52(11):1936-48. doi: 10.1194/jlr.M015552. Epub 2011 Sep 8. PubMed
Src homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and p38 regulate the expression of chemokine CXCL8 in human astrocytes. Mamik MK, Ghorpade A. PLoS One. 2012;7(9):e45596. doi: 10.1371/journal.pone.0045596. Epub 2012 Sep 21. PubMed
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. Ruess DA, Heynen GJ, Ciecielski KJ, Ai J, Berninger A, Kabacaoglu D, Gorgulu K, Dantes Z, Wormann SM, Diakopoulos KN, Karpathaki AF, Kowalska M, Kaya-Aksoy E, Song L, van der Laan EAZ, Lopez-Alberca MP, Nazare M, Reichert M, Saur D, Erkan MM, Hopt UT, Sainz B Jr, Birchmeier W, Schmid RM, Lesina M, Algul H. Nat Med. 2018 Jul;24(7):954-960. doi: 10.1038/s41591-018-0024-8. Epub 2018 May 28. PubMed
Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors. Heynen GJJE, Lisek K, Vogel R, Wulf-Goldenberg A, Alcaniz J, Montaudon E, Marangoni E, Birchmeier W. Breast Cancer Res. 2022 Apr 1;24(1):23. doi: 10.1186/s13058-022-01521-3. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.